| Description | DVL3 Human Pre-designed siRNA Set A contains three designed siRNAs for DVL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components DVL3 siRNA-1: 5 nmol (HPLC) DVL3 siRNA-2: 5 nmol (HPLC) DVL3 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 DVL3 Human Pre-designed siRNA Set A contains three designed siRNAs for DVL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components DVL3 siRNA-1: 5 nmol (HPLC) DVL3 siRNA-2: 5 nmol (HPLC) DVL3 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Inquire | Seals and prevents freezing of stopcocks and ground-glass joints in high-vacuum systems at pressures less than 10-6 mm Hg. Heat stable (?40 to 260 °C), low vapor pressure, and chemically resistant. Colorless. 5.3 oz. tube | Purity: >90%, by SDS-PAGE visualized with Coomassie® Blue Staining. Description: Major histocompatibility complex, class II, DR alpha (HLA-DRA) belongs to the MHC class II family. HLA-DRA binds peptides derived from antigens which access the endocytic route of antigen presenting cells (APC) Purity: >90%, by SDS-PAGE visualized with Coomassie® Blue Staining. Description: Major histocompatibility complex, class II, DR alpha (HLA-DRA) belongs to the MHC class II family. HLA-DRA binds peptides derived from antigens which access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for identification by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mainly by degradation of proteins which access the endocytic route, where they are processed by lysosomal proteases and other hydrolases... Read More | Format:10X ConcentrateProtein:Casein |